Elevance Health, Inc. (ELV)
402.63
+2.09
(+0.52%)
USD |
NYSE |
Aug 24, 16:00
402.58
-0.05
(-0.01%)
Pre-Market: 20:00
Elevance Health EPS Diluted (Quarterly) : 6.714 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.714 |
| March 31, 2026 | 8.004 |
| December 31, 2025 | 2.466 |
| September 30, 2025 | 5.315 |
| June 30, 2025 | 7.719 |
| March 31, 2025 | 9.608 |
| December 31, 2024 | 1.809 |
| September 30, 2024 | 4.359 |
| June 30, 2024 | 9.854 |
| March 31, 2024 | 9.590 |
| December 31, 2023 | 3.630 |
| September 30, 2023 | 5.450 |
| June 30, 2023 | 7.792 |
| March 31, 2023 | 8.298 |
| December 31, 2022 | 3.586 |
| September 30, 2022 | 6.618 |
| June 30, 2022 | 6.726 |
| March 31, 2022 | 7.32 |
| December 31, 2021 | 4.631 |
| September 30, 2021 | 6.134 |
| June 30, 2021 | 7.247 |
| March 31, 2021 | 6.708 |
| December 31, 2020 | 2.194 |
| September 30, 2020 | 0.8733 |
| June 30, 2020 | 8.912 |
| Date | Value |
|---|---|
| March 31, 2020 | 5.940 |
| December 31, 2019 | 3.620 |
| September 30, 2019 | 4.55 |
| June 30, 2019 | 4.364 |
| March 31, 2019 | 5.913 |
| December 31, 2018 | 1.609 |
| September 30, 2018 | 3.617 |
| June 30, 2018 | 3.983 |
| March 31, 2018 | 4.994 |
| December 31, 2017 | 4.674 |
| September 30, 2017 | 2.797 |
| June 30, 2017 | 3.158 |
| March 31, 2017 | 3.735 |
| December 31, 2016 | 1.371 |
| September 30, 2016 | 2.304 |
| June 30, 2016 | 2.910 |
| March 31, 2016 | 2.628 |
| December 31, 2015 | 0.675 |
| September 30, 2015 | 2.432 |
| June 30, 2015 | 3.132 |
| March 31, 2015 | 3.086 |
| December 31, 2014 | 1.80 |
| September 30, 2014 | 2.221 |
| June 30, 2014 | 2.556 |
| March 31, 2014 | 2.396 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| The Cigna Group | 6.289 |
| Centene Corp. | 2.192 |
| CVS Health Corp. | 2.315 |
| Humana, Inc. | 5.729 |
| Molina Healthcare, Inc. | 1.170 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.454B |
| Revenue (Quarterly) | 50.47B |
| Total Expenses (Quarterly) | 49.01B |
| Enterprise Value | 118.49B |
| Profit Margin (Quarterly) | 2.88% |
| Earnings Yield | 5.59% |
| Operating Earnings Yield | 8.21% |
| Normalized Earnings Yield | 5.588 |